Aeonvital
Founded Year
2021Stage
Seed - II | AliveAbout Aeonvital
Aeonvital focuses on the development of new personalized tumor immunotherapy products. Aeonvital mainly has two core technology platforms, one is a TILs cell therapy development platform for solid tumors; the other is a therapeutic nucleic acid vaccine development platform for precancerous lesions caused by HPV infection and cervical cancer. The company's products include cellular immunotherapy products and nucleic acid therapeutic vaccine products. The company was founded in 2021 and is based in Beijing, China.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Aeonvital Frequently Asked Questions (FAQ)
When was Aeonvital founded?
Aeonvital was founded in 2021.
Where is Aeonvital's headquarters?
Aeonvital's headquarters is located at Sihai Huachen Building, No. 33 Tianhua Street, Daxing District, Beijing.
What is Aeonvital's latest funding round?
Aeonvital's latest funding round is Seed - II.
Who are the investors of Aeonvital?
Investors of Aeonvital include Duowen Capital, Tianyu Healthcare Investment and Jintan Capital.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
